| |
Merck & Co., Inc.
Summary: According to a press release dated December 20, 2005, the 3rd U.S. Circuit Court of Appeals has now ruled that the investors' suit was properly dismissed because Merck had disclosed the nature of its subsidiary's improper accounting practices in an April 2001 filing with the Securities & Exchange Commission, and that the Journal reporter "simply did the math." Although the court was critical of Merck's failure to disclose the actual figures in its SEC filing, it nonetheless found that the essential facts had been disclosed to investors and analysts.
The original complaint allege that Merck overstated revenues from its subsidiary Merck-Medco Managed Care, L.L.C. by billions of dollars by including consumer co-payments for prescription drugs in its revenues. During the Class Period, Merk-Medco's revenues made up over 50% of Merck's total revenues. The lawsuit claims that Merck violated Generally Accepted Accounting Practices (GAAP) because neither company bills for the co-payments, gets billed for them, or otherwise comes into contact with co-payment money. Patients make co-payments directly to pharmacies when they purchase medicine.
On June 21, 2002, The Wall Street Journal issued a report regarding Merck's accounting practices and estimated that Merck and Merck-Medco may have pumped up their 2001 revenues by as much as $4.6 billion. Similar overstatements may have occurred for 1999 and 2000, the complaint says. That same day, according to the complaint, a Merck spokesman admitted that the company had been recording prescription drug co-payments as revenue since it acquired Merck-Medco in 1993.
In the wake of these revelations, Merck's stock immediately dropped 4.25% from its closing price of $52.20 on June 20, 2002 to a closing price of $49.98 on June 21, 2002, its lowest closing price since late 1997.
Through August 30, 2002, various plaintiff firms' motions for consolidation of all related actions and for the appointment of Lead Plaintiff and Lead Counsel were filed with the Court. The cases were consolidated on September 19, 2002. Lead Plaintiff, and their selection of Lead Counsel, was appointed on November 27, 2002. Lead Plaintiffs filed an Amended Complaint on March 17, 2003, which Defendants moved to dismiss on May 14, 2003. To date, the docket reflects no further significant activity.
INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector: Healthcare
Industry: Major Drugs
|
COMPANY/ISSUER NAME: |
Merck & Co., Inc. |
| COMPANY/ISSUER TICKER: |
MRK |
| COMPANY WEBSITE: |
http://www.merck.com |
| FIRST IDENTIFIED COMPLAINT IN THE DATABASE |
| Deutschl, et al. v. Merck & Co., Inc., et al. |
| COURT: D. New Jersey | DOCKET NUMBER: 02-CV-3185 |
| JUDGE NAME: Hon. Mary L. Cooper |
| DATE FILED: 07/01/2002 | SOURCE: Business Wires | | CLASS PERIOD START: 07/01/1999 | CLASS PERIOD END: 06/21/2002 | | TYPE OF COMPLAINT: Unamended/Unconsolidated | | PLAINTIFF FIRMS IN THIS OR SIMILAR CASE: |
Alfred G. Yates, Jr. 429 Forbes Avenue, Pittsburgh , PA, 15219
(voice) 412.391.5164, (fax) ,
Berman DeValerio Pease Tabacco Burt & Pucillo (MA) One Liberty Square, Boston, MA, 2109
(voice) 617.542.8300, (fax) 617.230.0903, info@bermanesq.com
Glancy and Binkow 1801 Avenue of the Stars, suite 311, Los Angeles, CA, 90067
(voice) 310-201-9150, (fax) , info@glancylaw.com
Holzer & Holzer, LLC 1117 Perimeter Center West, Suite E-107, Atlanta, GA, 30338
(voice) (770) 392-0090, (fax) (770) 392-0029, mfistel@holzerlaw.com
Kaplan Fox & Kilsheimer, LLP (San Francisco, CA) 100 Pine Street, 26th Floor, San Francisco, CA, 94111
(voice) 415.772.4700, (fax) 415.677.1233, info@kaplanfox.com
Kirby McInerney & Squire LLP 830 Third Avenue 10th Floor, New York Ave, NY, 10022
(voice) 212.317.2300, (fax) ,
Law Offices of Marc S. Henzel 335 Central Avenue, Lawrence, NY, 11559
(voice) 516.374.0707, (fax) 516.295.3473, securitiesfraud@comcast.net
LeBlanc & Waddell, LLC 201 St. Charles Avenue, Suite 3204, New Orleans, LA, 70170
(voice) 504.523.9900, (fax) 504.522.9300,
Lite, DePalma, Greenberg & Rivas, LLC Two Gateway Center, 12th Floor, Newark, NJ, 07102-5003y C
(voice) 973.623.3000, (fax) ,
Milberg Weiss Bershad Hynes & Lerach LLP (New York, NY) One Pennsylvania Plaza, New York, NY, 10119-1065
(voice) 212.594.5300, (fax) ,
Rabin & Peckel LLP 275 Madison Avenue, 34th Floor, New York, NY, 10016
(voice) 212.682.1818, (fax) 212.682.1892, email@rabinlaw.com
Shapiro Haber & Urmy LLP 75 State Street, Boston, MA, 02109
(voice) 617.439.3939, (fax) 617.439.0134, info@shulaw.com
Spector Roseman & Kodroff (San Diego) 1818 Market Street, Suite 2500, Philadelphia, PA, 19103
(voice) 215.496.0300, (fax) 215.496.6611,
Wechsler Harwood LLP 488 Madison Avenue 8th Floor, New York, NY, 10022
(voice) 212.935.7400, (fax) , info@whhf.com
Weiss & Yourman (New York, NY) The French Building, 551 Fifth Ave., Suite 1600, New York, NY, 10126
(voice) 212.682.3025, (fax) 212.682.3010, info@wyca.com
Wolf Popper, LLP 845 Third Avenue, New York, NY, 10022-6689Ave
(voice) 877.370.7703, (fax) 212.486.2093, IRRep@wolfpopper.com
_____________________________________________ TOTAL NUMBER OF PLAINTIFF FIRMS: 16 | | REFERENCE COMPLAINT | | In Re: Merck & Co., Inc. Securities Litigation | | COURT: D. New Jersey | DOCKET NUMBER: 02-CV-3185 | | JUDGE NAME: Hon. Stanley R. Chesler | | DATE FILED: 03/21/2003 | SOURCE: Business Wires | | CLASS PERIOD START: 01/26/2000 | CLASS PERIOD END: 07/09/2002 | | TYPE OF COMPLAINT: Consolidated and/or Amended | | PLAINTIFF FIRMS NAMED IN COMPLAINT: |
Bernstein Litowitz Berger & Grossmann LLP (New York, NY) 1285 Avenue of the Americas, 33rd Floor, New York, NY, 10019
(voice) 212.554.1400, (fax) 212.554.1444, blbg@blbglaw.com
Bernstein Litowitz Berger & Grossmann LLP (Westfield, NJ) 220 St. Paul Street, Westfield, NJ, 07090
(voice) 908.928.1700, (fax) 908.301.9008, blbg@blbglaw.com
_____________________________________________ TOTAL NUMBER OF PLAINTIFF FIRMS: 2 | | WARNING AND DISCLAIMER OF LIABILITY: The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful. Go to Search page | Go to Case Index page | Back to Top
|